Science review: vasopressin and the cardiovascular system part 1–receptor physiology

CL Holmes, DW Landry, JT Granton - Critical care, 2003 - Springer
Vasopressin is emerging as a rational therapy for vasodilatory shock states. Unlike other
vasoconstrictor agents, vasopressin also has vasodilatory properties. The goal of the …

[PDF][PDF] X-linked hypercalciuric nephrolithiasis: clinical syndromes and chloride channel mutations

SJ Scheinman - Kidney international, 1998 - core.ac.uk
The original report of this family included several patients with moderate renal insufficiency
in whom calcium excretion was normal [1], but with further study of a larger number of …

Nephrogenic diabetes insipidus. A V2 vasopressin receptor unable to stimulate adenylyl cyclase

W Rosenthal, A Antaramian, S Gilbert… - Journal of Biological …, 1993 - Elsevier
The coding region of the human vasopressin type 2 receptor gene bears mutations in the
individuals affected with congenital nephrogenic diabetes insipidus, a disease characterized …

Structure and chromosomal localization of the human antidiuretic hormone receptor gene.

A Seibold, P Brabet, W Rosenthal… - American journal of …, 1992 - ncbi.nlm.nih.gov
Applying a genomic DNA-expression approach, we cloned the gene and cDNA coding for
the human anti-diuretic hormone receptor, also called" vasopressin V2 receptor"(V2R). The …

Nephrogenic diabetes insipidus

DG Bichet - The American journal of medicine, 1998 - Elsevier
In nephrogenic diabetes insipidus, the kidney is unable to concentrate urine despite normal
or elevated concentrations of the antidiuretic hormone arginine vasopressin (AVP). In …

X-linked nephrogenic diabetes insipidus mutations in North America and the Hopewell hypothesis.

DG Bichet, MF Arthus, M Lonergan… - The Journal of …, 1993 - Am Soc Clin Investig
In X-linked nephrogenic diabetes insipidus (NDI) the urine of male patients is not
concentrated after the administration of the antidiuretic hormone arginine-vasopressin. This …

Heterogeneous AVPR2 gene mutations in congenital nephrogenic diabetes insipidus.

RS Wildin, MJ Antush, RL Bennett… - American journal of …, 1994 - ncbi.nlm.nih.gov
Mutations in the AVPR2 gene encoding the receptor for arginine vasopressin in the kidney
(V2 ADHR) have been reported in patients with congenital nephrogenic diabetes insipidus …

Identification and characterization of a novel X-linked AVPR2 mutation causing partial nephrogenic diabetes insipidus: a case report and review of the literature

V Neocleous, N Skordis, C Shammas, E Efstathiou… - Metabolism, 2012 - Elsevier
X-linked nephrogenic diabetes insipidus (NDI) is a rare disease characterized by a
malfunctioning renal response to the antidiuretic hormone arginine vasopressin (AVP) due …

The vasopressin–aquaporin-2 pathway syndromes

G Valenti, G Tamma - Handbook of Clinical Neurology, 2021 - Elsevier
Vasopressin is the key hormone involved in water conservation and regulation of water
balance, essential for life. In the renal collecting duct, vasopressin binds to the V2 receptor …

Vasopressin in heart failure

M Iovino, M Iacoviello, G De Pergola… - … Metabolic & Immune …, 2018 - ingentaconnect.com
Background and Objective: The nonapeptide hypothalamic hormone vasopressin (VP),
exerts important effects on cardiovascular system via its receptors V1, V2 and V3. Patients …